US Broker Ratings

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a 142% Potential Upside

ADMA Biologics Inc. (NASDAQ: ADMA) is capturing the attention of investors with its promising potential for growth in the biotechnology sector. The company, with a market capitalization of $2.31 billion,..

Oscar Health, Inc. (OSCR) Stock Analysis: 6.57% Potential Upside Amidst Healthcare Sector Dynamics

Oscar Health, Inc. (NYSE: OSCR) is drawing attention within the healthcare sector with its innovative approach to providing health plans and technology-driven solutions. Operating within the healthcare plans industry, Oscar..

Grifols, S.A. (GRFS) Stock Analysis: Unveiling a 35% Potential Upside for Investors

Grifols, S.A. (NASDAQ: GRFS), a healthcare giant specializing in plasma-derived medicines and technologies, is capturing the attention of investors with a promising 35.20% potential upside. With its substantial market cap..

Corcept Therapeutics (CORT) Investor Outlook: A Promising Upside in the Biotech Sector

Corcept Therapeutics Incorporated (NASDAQ: CORT), a notable player in the biotechnology sector, is drawing attention from investors with its promising potential upside of 60.82%. This Redwood City, California-based company is..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Strong Potential Upside Amidst Healthcare Market

Inspire Medical Systems, Inc. (NYSE: INSP), a leading player in the healthcare sector, has been making waves in the medical devices industry with its innovative solutions for obstructive sleep apnea..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Navigating Volatility with Strategic Biotech Innovations

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) is a prominent name in the biotechnology sector, focusing on groundbreaking genetic therapeutics for rare diseases. Despite its cutting-edge advancements, the company is navigating a..

Charles River Laboratories (CRL) Stock Analysis: Navigating Growth Potentials with a 12.52% Upside

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a prominent player in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $8.67 billion,..

BrightSpring Health Services, I (BTSG) Stock Analysis: A 16% Upside Potential in the Healthcare Sector

BrightSpring Health Services, Inc. (BTSG) is capturing investor attention with its robust 16.04% potential upside, as indicated by its average target price of $52.60. This promising outlook is bolstered by..

Alcon Inc. (ALC) Stock Analysis: Exploring a 22% Potential Upside in the Healthcare Sector

Alcon Inc. (NYSE: ALC), a leader in the healthcare sector specializing in medical instruments and supplies, is captivating investor attention with a notable potential upside of 22.17% from its current..

ICON plc (ICLR) Stock Analysis: Navigating a 23.66% Potential Upside in the Healthcare Sector

ICON plc (NASDAQ: ICLR), a leading clinical research organization headquartered in Dublin, Ireland, presents a compelling opportunity for investors in the healthcare sector. The company, with a market capitalization of..

The Ensign Group, Inc. (ENSG) Stock Analysis: Healthcare Giant with a 10.74% Potential Upside

The Ensign Group, Inc. (ENSG), a prominent player in the healthcare sector, has captured investor attention with its robust market cap of $11.63 billion and a promising potential upside of..

Waystar Holding Corp. (WAY) Stock Analysis: A 67.85% Upside Potential in Healthcare Tech

For investors looking for opportunities in the burgeoning healthcare technology sector, Waystar Holding Corp. (WAY) presents a compelling case with a standout potential upside of 67.85%. With a market capitalization..

TransMedics Group, Inc. (TMDX) Stock Analysis: Strong Buy Ratings and Potential 36% Upside

TransMedics Group, Inc. (NASDAQ: TMDX) has been capturing investor attention with its innovative approach to organ transplant therapy and a robust market performance. With a market capitalization of $3.91 billion,..

Avantor, Inc. (AVTR) Stock Analysis: Is a 36% Upside on the Horizon?

Avantor, Inc. (NYSE: AVTR), a key player in the healthcare sector, operates within the medical instruments and supplies industry, providing vital products and services to a diverse set of industries..

Boston Scientific Corporation (BSX) Stock Analysis: A Compelling 59.76% Potential Upside and Strong Buy Consensus

Boston Scientific Corporation (NYSE: BSX) is making waves in the healthcare sector, specifically within the medical devices industry. With a robust market capitalization of $91.83 billion, the company has successfully..

Stryker Corporation (SYK) Stock Analysis: Unpacking a 24% Potential Upside in the Medical Device Sector

Stryker Corporation (NYSE: SYK), a prominent player in the healthcare sector, commands attention with its robust market capitalization of $129.89 billion. Operating within the medical devices industry, Stryker has carved..

Krystal Biotech, Inc. (KRYS) Investor Outlook: Exploring a 21% Upside Potential Amid Biotech Innovation

Krystal Biotech, Inc. (NASDAQ: KRYS), a trailblazer in the biotechnology sector, is capturing the attention of investors with its innovative approach to genetic medicine. With a market capitalization of $7.62..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: A Closer Look at Growth Potential and Market Position

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) stands as a formidable player within the medical devices industry, holding its ground in the competitive healthcare sector. With a market capitalization of $18.22..

Veeva Systems Inc. (VEEV) Stock Report: Analyzing the 76.3% Upside Potential for Savvy Investors

Veeva Systems Inc. (NYSE: VEEV) has long been a prominent player in the health information services sector, catering to the unique needs of the life sciences industry. With a market..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: A Healthcare Giant with a 6.97% Potential Upside

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a major player in the global pharmaceutical industry, presents an intriguing opportunity for investors with its potential 6.97% upside. Headquartered in Hyderabad, India, Dr...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds